MVK
MVK (mevalonate kinase, also known as LRBP and MK) is a GHMP family kinase that catalyses the phosphorylation of mevalonate to mevalonate 5-phosphate. This is a key early step in isoprenoid and cholesterol biosynthesis. Browse Assay Genie's current range of MVK research reagents below, or read on for the biology behind the target.
MVK encodes mevalonate kinase, which catalyses the phosphorylation of mevalonate to give mevalonate 5-phosphate. Mevalonate is a key intermediate in isoprenoid and sterol synthesis, and mevalonate kinase acts as a key early enzyme in that route, making this step central to isoprenoid and cholesterol biosynthesis.
The enzyme belongs to the GHMP kinase family, mevalonate kinase subfamily, and HGNC places the MVK gene in the group of isoprenoid biosynthesis kinases. UniProt records the protein in the cytoplasm and peroxisome, and the NCBI Gene summary describes it as a peroxisomal enzyme. Alternative splicing of the gene results in multiple transcript variants. The mouse and rat orthologs are both named Mvk.
The gene has also been listed as LRBP and MK, and an earlier HGNC name was mevalonate kinase (mevalonic aciduria). That name reflects its disease relevance: mevalonate kinase deficiency, caused by mutation of this gene, results in mevalonic aciduria. This disease is characterised by psychomotor retardation, failure to thrive, hepatosplenomegaly, anaemia and recurrent febrile crises. Defects in the same gene also cause hyperimmunoglobulinaemia D and periodic fever syndrome, a disorder of recurrent fever episodes associated with lymphadenopathy, arthralgia, gastrointestinal upset and skin rash.
Mevalonate kinase is a key early enzyme in isoprenoid and sterol synthesis, so MVK is a natural focus for studies of this pathway.
By phosphorylating mevalonate, MVK carries out a key step in cholesterol biosynthesis, relevant to research on sterol production.
Defects in MVK cause hyperimmunoglobulinaemia D and periodic fever syndrome, a disorder of recurrent fever, lymphadenopathy and arthralgia.
Mutation of MVK causes mevalonic aciduria, which involves psychomotor retardation, failure to thrive and hepatosplenomegaly, making the gene relevant to inherited metabolic disease research.
MVK encodes mevalonate kinase, which catalyses the phosphorylation of mevalonate to mevalonate 5-phosphate. This is a key early step in isoprenoid and cholesterol biosynthesis. UniProt places the enzyme in the cytoplasm and peroxisome, and classifies it in the GHMP kinase family.
MVK is also known as LRBP and MK, and its former HGNC name was mevalonate kinase (mevalonic aciduria). The enzyme carries the EC number 2.7.1.36. According to the NCBI Gene summary, alternative splicing of the gene results in multiple transcript variants.
Mutation of the MVK gene causes mevalonate kinase deficiency, which results in mevalonic aciduria. Defects in the gene also cause hyperimmunoglobulinaemia D and periodic fever syndrome. Mouse and rat both have an ortholog named Mvk; check the datasheet of any product for its validated reactivity.
Other isoprenoid biosynthesis enzymes and cholesterol pathway targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q03426; product specifications from Assay Genie datasheets.